Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Veyong Biochemical’s 5,000-tons glufosinate project scheduled for operation at end of Q3 2022qrcode

Jul. 18, 2022

Favorites Print
Jul. 18, 2022

After the end of the first half of 2022, Veyong Biochemical, a wholly owned subsidiary of China's Limin Group, has overcome the difficulties it encountered in terms of strict environmental compliance inspections, which affected the progress of construction of its 5,000-tons glufosinate project in the first half of the year. Therefore, Veyong Biochemical can continue the construction of the project and ensure overall progress as planned. 

Currently, the construction of the project’s buildings is nearly complete while installation work is 85% complete. The overall commissioning and trial run will be conducted in September, and the project is planned to be completed and enter operation by the end of the third quarter of 2022.

The project is one of the three major projects of the Limin Group. With its completion in the second half of the year, Veyong Biochemical is fast-tracking its development. Moreover, Veyong Biochemical will continue to advance its research and development and industrialized production of L-glufosinate, which will pave the way for subsequent product planning and establish a solid foundation for the sustainable and high-quality development of the herbicide products of the Limin Group. 


Source: AgroNews


More from AgroNewsChange

Hot Topic Change

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  



Subscribe to daily email alerts of AgroNews.